FindTrial
Sign In

Natural killer (NK) cells

BIOLOGICAL2 trials

Sponsors

Masonic Cancer Center, University of Minnesota, Brenda Cooper, MD

Conditions

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAdenocarcinoma of RectumChronic Lymphocytic LeukemiaChronic Myeloid LeukemiaColon CarcinomaEwing's SarcomaHodgkin Lymphoma

Phase 1

Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
CompletedNCT02890758
Brenda Cooper, MDAcute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma of Rectum +11
Start: 2018-05-22End: 2023-02-17Updated: 2023-02-21

Phase 2

Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes
CompletedNCT01593670
Masonic Cancer Center, University of MinnesotaMyelodysplastic Syndrome
Start: 2013-03-31End: 2018-10-23Updated: 2019-05-21